Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone

R. Douglas Bruce, Frederick L. Altice, David E. Moody, Shen-Nan Lin, Wenfang B. Fang, John P. Sabo, Jan M. Wruck, Peter J. Piliero, Carolyn Conner, Laurie Andrews, Gerald FriedlandDrug 2009 · DOI

BibTeX
@inproceedings{bruce2009pharmacokinetic,
  author = {R. Douglas Bruce and Frederick L. Altice and David E. Moody and Shen-Nan Lin and Wenfang B. Fang and John P. Sabo and Jan M. Wruck and Peter J. Piliero and Carolyn Conner and Laurie Andrews and Gerald Friedland},
  title = {{Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone}},
  booktitle = {Drug},
  year = {2009},
  doi = {10.1016/j.drugalcdep.2009.07.007},
}

Loading related content...

Figure